Why do so many European biotechnology
companies fail? This book finds an answer in the behaviour of the investors
who dominate the industry and control the behaviour of the companies they
invest in. Starting from a detailed analysis of the history of the industry
from its earliest days, thus book cuts through the hype and mythology
to identify what really happened to the biotechnology industry in Europe,
what went wrong with the business, the management and the investment,
and who are the controlling figures that made it happen. Bains uses real
case studies and a wealth of statistical data to show how systematic under-investment
and extraordinary business decisions have made European companies stunted
mimics of their US counterparts. Building on an inside knowledge of how
Venture Capital really works, he shows how this is not an accidental side-product
of European inexperience or lack of business acumen, but a necessary result
of how Venture Capitalists run their businesses in Europe. This is an
essential book for entrepreneurs, investors and policy-makers alike, as
well as being a valuable information source for anyone interested in how
high-tech businesses are created.
|